BioPorto A/S

kr 0.99As of Sun 8 Nov 2026, 12:00 UTC
CPH:BIOPORHealthcare
Country Denmark
PE (Fwd) •••
TSR 10Y CAGR (3.05%)
Div yield —
ROE (25.73%)
Diagnostics & Research
Beta (5Y) 1.30
PE TTM —
TSR TTM (21.92%)
Mkt cap kr 490.2M
ROIC (11.04%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 1.17
18.10%
(3.05%)
Buy 11|0|2|1|5
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.01
0.01
0.01
0.01
(5.46%)
(3.59%)
(5.24%)
(4.38%)
Revenuekr M
32.63
31.66
30.74
31.84
1.72%
1.67%
(3.84%)
(2.28%)
Peers (US$73.07M)
Cap (US$)
PE
10.79M
—
9.164M
—
Capital
TTM
5Y
10Y
Leveragex
0.456
(0.046)
(0.045)
EBIT/Intx
0.944
0.393
0.362
Own earn%
(13.97)
(172.00)
(158.63)
Sh yield%
24.51
45.75
46.01
Owners
Insiders/Inst%
7.38
51.69
Short interest%
1.36
SBC / revenue%
5.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
15–25
$1 testx
—
Incr. ROIC%
15